Revive Therapeutics Ltd (RVVTF)

$0.02 +0.00 (13.22%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 46,900
Avg Vol 233,700
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 58%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin, which i...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 888-901-0036
Fax: 905-248-3355
Address:
The Canadian Venture Building, 82 Richmond Street East, Toronto, Canada
Tbickle
Tbickle Jul. 4 at 9:58 PM
$RVVTF
0 · Reply
Bulldog_Retired
Bulldog_Retired Jul. 2 at 9:07 PM
$RVVTF just a comment that as relations with US have been a bit rocky, Canada has flexed as a leader in NATO and is now pushing for a global defence bank. no exact connection to the DRDC study, but if they did opt to stock $RVVTF's products, they might talk multiple countries into also stocking it. https://www.reuters.com/world/canada-aims-announce-10-countries-backing-global-defence-bank-nato-summit-2026-07-02/
1 · Reply
Tartufo
Tartufo Jul. 2 at 5:45 PM
$RVVTF when you least expect it this will explode, GLTA!
0 · Reply
LifesGood
LifesGood Jul. 2 at 2:11 PM
$RVVTF I'm still
0 · Reply
Barron401k
Barron401k Jul. 2 at 1:53 PM
$RVVTF this is what the free market ACTUALLY looks like when all the scum bag market makers are "on holiday"
0 · Reply
Comonbaby
Comonbaby Jul. 2 at 1:49 PM
$RVVTF 20% on open, that's a win
0 · Reply
Tbickle
Tbickle Jul. 2 at 1:51 AM
$RVVTF with three clear multi million dollar markets 1) 5 eyes stockpiling contracts, 2) civilian pesticide poisoning and 3) traumatic brain injury and using a pro-forma revenue projection model for the 3 specific 5m (500 million) mkts against a standard pharmaceutical price to earnings multiple P/E and Revives current share structure the stimated five year price target is 12.50 to 25.00 smackers per share
5 · Reply
Canadianbull1324
Canadianbull1324 Jul. 1 at 12:23 PM
$RVVTF Happy Canada Day to all!! 🇨🇦🇨🇦🇨🇦🇨🇦🇨🇦🇨🇦
0 · Reply
Tbickle
Tbickle Jul. 1 at 7:38 AM
$RVVTF In the defense and biotech industries, a combination of a military gag order, aggressive international patenting, and a corporate pivot, is a clear signal that buci is an incribly valuable billion dollar asset
1 · Reply
DidYouReadThis
DidYouReadThis Jun. 30 at 11:16 PM
$RVVTF new here. Can you give me a timeline/elevator pitch and brief history? Thank you!
3 · Reply
Latest News on RVVTF
No data available.
Tbickle
Tbickle Jul. 4 at 9:58 PM
$RVVTF
0 · Reply
Bulldog_Retired
Bulldog_Retired Jul. 2 at 9:07 PM
$RVVTF just a comment that as relations with US have been a bit rocky, Canada has flexed as a leader in NATO and is now pushing for a global defence bank. no exact connection to the DRDC study, but if they did opt to stock $RVVTF's products, they might talk multiple countries into also stocking it. https://www.reuters.com/world/canada-aims-announce-10-countries-backing-global-defence-bank-nato-summit-2026-07-02/
1 · Reply
Tartufo
Tartufo Jul. 2 at 5:45 PM
$RVVTF when you least expect it this will explode, GLTA!
0 · Reply
LifesGood
LifesGood Jul. 2 at 2:11 PM
$RVVTF I'm still
0 · Reply
Barron401k
Barron401k Jul. 2 at 1:53 PM
$RVVTF this is what the free market ACTUALLY looks like when all the scum bag market makers are "on holiday"
0 · Reply
Comonbaby
Comonbaby Jul. 2 at 1:49 PM
$RVVTF 20% on open, that's a win
0 · Reply
Tbickle
Tbickle Jul. 2 at 1:51 AM
$RVVTF with three clear multi million dollar markets 1) 5 eyes stockpiling contracts, 2) civilian pesticide poisoning and 3) traumatic brain injury and using a pro-forma revenue projection model for the 3 specific 5m (500 million) mkts against a standard pharmaceutical price to earnings multiple P/E and Revives current share structure the stimated five year price target is 12.50 to 25.00 smackers per share
5 · Reply
Canadianbull1324
Canadianbull1324 Jul. 1 at 12:23 PM
$RVVTF Happy Canada Day to all!! 🇨🇦🇨🇦🇨🇦🇨🇦🇨🇦🇨🇦
0 · Reply
Tbickle
Tbickle Jul. 1 at 7:38 AM
$RVVTF In the defense and biotech industries, a combination of a military gag order, aggressive international patenting, and a corporate pivot, is a clear signal that buci is an incribly valuable billion dollar asset
1 · Reply
DidYouReadThis
DidYouReadThis Jun. 30 at 11:16 PM
$RVVTF new here. Can you give me a timeline/elevator pitch and brief history? Thank you!
3 · Reply
JTM67
JTM67 Jun. 30 at 5:45 PM
$RVVTF RVVTF will be a strong candidate for a "buy out" or "merger" a year from now if all goes well...
0 · Reply
Comonbaby
Comonbaby Jun. 30 at 3:15 PM
$RVVTF Financials due, delayed study results, last day of the month, holiday tomorrow... bases are loaded.
1 · Reply
BobWarner99
BobWarner99 Jun. 30 at 2:11 PM
$RVVTF Interesting....
1 · Reply
Tbickle
Tbickle Jun. 30 at 8:53 AM
$RVVTF by shifting the company away from shrooms, the company is signaling that bucillamine is a franchise asset that will transform the company from a micro cap biotech to a billion dollar company
1 · Reply
Mitchz11
Mitchz11 Jun. 30 at 4:56 AM
$RVVTF Am I the only dreaming that everything goes right and we somehow hit $5. Like I know realistically if this does amazing we can get to $1 but there is that crazy dream scenario we this thing blows up and we go to the moon. Like I feel that we actually have a leg to stand on to do that. Not a strong leg but something.
2 · Reply
BobWarner99
BobWarner99 Jun. 30 at 1:35 AM
$RVVTF Is June 30th 2026 possibly a big day for ticker RVVTF?? MF's Audited financials are due tomorrow, June 30th 2026. Will he deliver? Ask for an extension?? Is it possible that the DRDC has positive results ready to be released.....but waiting for MF's audited financials 1st? Would the DRDC prefer that RVVTF that have the limited information tag removed? Would the market respond much better to positive results and having the limited information tag on otcmarkets removed from RVVTF? Or is tomorrow a nothing burger?? We'll see.....
1 · Reply
Tbickle
Tbickle Jun. 29 at 7:55 PM
$RVVTF pesticides use the exact same chemical mechanisms as chemical nerve agents like sarin. If the military trial proves that buci prevents brain injury from nerve agents it automatically applies to agricultural pesticide poisoning. This represents a massive emergency civilian market.
2 · Reply
BobWarner99
BobWarner99 Jun. 29 at 7:45 PM
$RVVTF Bid Size .011??
1 · Reply
Dirtymartini66
Dirtymartini66 Jun. 29 at 5:37 PM
$RVVTF we've been flat-lined for a while/ no trades - probably nothing - don't see any news of a trading halt - but sure would be nice if that was the reason - best wishes all!
0 · Reply
Tbickle
Tbickle Jun. 29 at 12:04 AM
$RVVTF given the extended trial length the gag order and the sitting on results its likely theyll drop stellar data a stockpiling contract AND a manufacturing grant simultaneously
3 · Reply
sica1983
sica1983 Jun. 27 at 10:19 PM
$RVVTF So in Revive history there have essentially been three major periods of investor enthusiasm: • 2015: Bucillamine/gout clinical progress. • 2017: Cannabis and cannabinoid pipeline expansion during a hot cannabis market. • 2020-2021: Bucillamine Phase 3 COVID trial, when the stock again traded around $0.50-0.55. Each time stock surged to 0.40-0.50 cents area. Could the DRDC program become the biggest catalyst in the company’s history? Yes, if it ultimately results in validated efficacy and government procurement or broader adoption.
3 · Reply
sica1983
sica1983 Jun. 27 at 9:47 PM
$RVVTF Revive need money for day to day operations, so they need to raise money from time to time. The offering terms are pretty good in my opinion, the units were priced above where the common shares had recently been trading, which is generally a stronger signal and the investors are committing new capital, suggesting they see value at that price. The company is raising money to continue operations rather than issuing shares at an extremely distressed valuation. For existing shareholders, I’d characterize these terms as reasonably shareholder-friendly relative to what is often seen in small biotech companies.
1 · Reply